WebMay 28, 2008 · Fibroblast growth factor 21 (FGF21) is active in murine adipocytes and has beneficial metabolic effects in animal models of type 2 diabetes mellitus. We assessed whether FGF21 influences lipolysis in human adipocytes and 3T3-L1 cells. FGF21 had no short-time effect (h) while a 3-day incubation with FGF21 attenuated hormone-stimulated … WebAutophagic flux was monitored by laser confocal microscopy and western blot. Results showed that FGF21 significantly reduced body weight (P < 0.01) and serum triglyceride, improved insulin sensitivity, and reversed hepatic steatosis in the MSG model mice.
FGF21 regulates insulin sensitivity following long-term …
WebAug 6, 2024 · FGF21 exerts its beneficial pharmacological effects on adiposity, insulin sensitivity, glucose and lipid metabolism, and vascular homeostasis through its actions … WebFGF21 stimulates hepatic fatty acid oxidation and reduces lipid flux into the liver by increasing peripheral lipoprotein catabo-lism and reducing adipocyte lipolysis. Paradoxically, and de - spite its beneficial action, FGF21 is elevated in insulin resistance states, that is, fatty liver, obesity, and type 2 diabetes. 203 q99 roanoke va christmas
National Center for Biotechnology Information
WebInsulin resistance occurs in most T2DM patients and forms obesity linked to metabolic syndrome. Increasing insulin sensitivity decreases abnormal glucose metabolism. The process of insulin signal transduction involves tyrosine phosphorylation in the insulin-receptor activation pathway. ... Fibroblast growth factor 21 (FGF21) is a metabolic ... WebSep 1, 2024 · Fibroblast growth factor 21 (FGF21) ... glucose and lipid metabolism, and insulin sensitivity. In addition, FGF21 also acts directly through its coreceptor β-klotho in the brain to alter light-dark cycle activity. In this review, we critically appraise current advances in understanding the physiological actions of FGF21 and its role as a ... WebJul 21, 2024 · Experimental fibroblast growth factor 21 (FGF21) analogs can improve lipid profiles in patients with metabolic diseases. However, their effects on markers of insulin sensitivity appear to be minimal, potentially because of insufficient exposure. domino magazine podcast